humulin r solution for injection
lilly france s.a.s. - insulin human regular (recombinant dna) - solution for injection - 100iu/ml
humulin n suspension for injection
lilly france s.a.s. - insulin human isophane (recombinant dna) - suspension for injection - 100iu/ml
kirsty insulin aspart injection (rdna origin) 100 uml
biocon sdn bhd - insulin aspart -
humulin n suspension for injection
lilly france s.a.s. - insulin human isophane (recombinant dna) - suspension for injection - 100iu/ml
humulin r solution for injection
lilly france s.a.s. - insulin human regular (recombinant dna) - solution for injection - 100iu/ml
humanext-n 10ml vial
cadila - neutral insulin/isophane insulin/lente insulin/extended insulin zinc sus./premixed biphasic insulin - vial - 40iu./ml(human insulin recombinant dna origin) - 10ml
humulin i
eli lilly & co. limited - insulin recombinant, human - suspension for injection - insulin recombinant, human 100 iu/ml - drugs used in diabetes
humulin s
eli lilly & co. limited - insulin recombinant, human - solution for injection - insulin recombinant, human 100 iu/ml - drugs used in diabetes
humulin m3
eli lilly & co. limited - insulin recombinant, human - suspension for injection - insulin recombinant, human 100 iu/ml - drugs used in diabetes
humalog mix75/25- insulin lispro injection, suspension
physicians total care, inc. - insulin lispro (unii: gfx7qis1ii) (insulin lispro - unii:gfx7qis1ii) - insulin lispro 100 [iu] in 1 ml - humalog mix75/25, a mixture of 75% insulin lispro protamine suspension and 25% insulin lispro injection, (rdna origin), is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia. humalog mix75/25 has a more rapid onset of glucose–lowering activity compared with humulin 70/30 while having a similar duration of action. this profile is achieved by combining the rapid onset of humalog with the intermediate action of insulin lispro protamine suspension. humalog mix75/25 is contraindicated during episodes of hypoglycemia and in patients sensitive to insulin lispro or any of the excipients contained in the formulation.